BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Allergy to pollen
,
Heart
,
Metabolism of nitric oxide
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
regulation of GTP binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Frontal cortex
Ascending colon
Colon
Cerebellar hemisphere
Cerebellar vermis
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Peritoneal foreign body
Disorder of pregnancy
Sendai virus infection
Pneumonia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
JM 3100
indole
STI571
triptolide
ACVR2B protein, human
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TBC1D23
PCDH11X
SULF1
TSC2
LAT
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
MiRNA profiling during infection with H7N7 influenza A virus
5-fluorouracil resistant and sensitive colon cancer cells microRNA expression profiles
MicroRNA expression profiles of interstitial lung disease (ILD) patients
Prostate cancer associated fibroblasts and prostate fibroblasts activated w/ TGFb1 or IL6 - [miRNA]
Carcinoma Associated Fibroblasts and stroma of Non-small cell lung cancer tumors
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for regulation of GTP binding
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients
BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
Tarlox and Sotorasib in Patients With KRAS G12C Mutations
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ